Disease/Infection News

RSS

State-level economic policy associated with reduction in HIV risk behavior among single mothers

UCLA research finds that a refundable State-level Earned Income Tax Credit (SEITC) of 10% or above the Federal EITC was associated with a 21% relative risk reduction in reported behavior that could put single mothers at high risk for becoming infected with HIV during the previous year.

30 Aug 2022

Italian study finds SARS-CoV-2 in clinical samples collected before December 2019

Researchers discuss the association of SARS-CoV-2 with morbilliform skin rash and confirms viral circulation in September 2019.

30 Aug 2022

Does Langya virus pose a spillover threat?

Researchers assess the potential impact of the Langya virus, its current risk, and what measures might help to contain this virus.

30 Aug 2022

Abdominal obesity increases risk of pancreatic cancer

Researchers report that abdominal obesity determined by body mass index adjusted waist-to-hip ratio is a significant risk factor for pancreatic cancer.

30 Aug 2022

Vitamin D mediates crosstalk between COVID-19 and osteoporosis

Researchers identify and characterize the targets of Vit D on COVID-19 and osteoporosis.

30 Aug 2022

What is the infectivity of SARS-CoV-2 Omicron BA.2.75 variant?

Researchers recently assessed the infectivity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.2.75 variant compared to preexisting variants.

30 Aug 2022

SARS-CoV-2 Omicron BA.2.75 replicates more efficiently than BA.2 or BA.5 sub-variants

In a new study, researchers characterized the clinical isolates of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.2.75 sub-variant.

30 Aug 2022

Study explores differences in the efficiency of COVID-19 vaccine boosters

In a new study, researchers predicted the efficacy of coronavirus disease 2019 (COVID-19) vaccine boosters.

30 Aug 2022

COVID-19 may provoke IgA-associated vasculitis

In a new study, scientists showed that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection provokes immunoglobulin A (IgA)-associated vasculitis (IgAV).

30 Aug 2022

Research reveals administration of ineffective COVID-19 treatments after FDA deauthorization

Monoclonal antibodies are laboratory-designed treatments tailor-made to fight specific infections. In early 2021, the U.S. Food & Drug Administration issued emergency use authorization for two monoclonal antibodies (bamlanivimab/etesevimab and casirivimab/imdevimab) for the treatment of mild to moderate COVID-19 in high-risk, non-hospitalized patients.

30 Aug 2022

Understanding recombination rates in RNA viruses

...

30 Aug 2022

Researchers review sexual well-being during the SARS-CoV-2 pandemic

Researchers conducted a scoping review on sexual well-being during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.

30 Aug 2022

Relapse of COVID-19 symptoms and SARS-CoV-2 viral load following nirmatrelvir/ritonavir treatment

Researchers reported rapid relapse of COVID-19 symptoms following the administration of nirmatrelvir/ritonavir in adults.

30 Aug 2022

Study reveals impacts of multiple SARS-CoV-2 Wuhan-based vaccinations on the Omicron variant of concern

In a new study, researchers analyzed the influence of multiple shots of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Wuhan strain vaccinations on the Omicron variant.

30 Aug 2022

Novel mechanism identified that SARS-CoV-2 uses to suppress antiviral responses to make the cell more permissive to infection

Researchers assessed the impact of SARS-CoV-2 ORF-6 on innate immune signaling.

30 Aug 2022

Disease/Infection News

State-level economic policy associated with reduction in HIV risk behavior among single mothers

Italian study finds SARS-CoV-2 in clinical samples collected before December 2019

Does Langya virus pose a spillover threat?

Abdominal obesity increases risk of pancreatic cancer

Vitamin D mediates crosstalk between COVID-19 and osteoporosis

What is the infectivity of SARS-CoV-2 Omicron BA.2.75 variant?

SARS-CoV-2 Omicron BA.2.75 replicates more efficiently than BA.2 or BA.5 sub-variants

Study explores differences in the efficiency of COVID-19 vaccine boosters

COVID-19 may provoke IgA-associated vasculitis

Research reveals administration of ineffective COVID-19 treatments after FDA deauthorization

Understanding recombination rates in RNA viruses

Researchers review sexual well-being during the SARS-CoV-2 pandemic

Relapse of COVID-19 symptoms and SARS-CoV-2 viral load following nirmatrelvir/ritonavir treatment

Study reveals impacts of multiple SARS-CoV-2 Wuhan-based vaccinations on the Omicron variant of concern

Novel mechanism identified that SARS-CoV-2 uses to suppress antiviral responses to make the cell more permissive to infection

UK survey reveals outlook of the public towards health information circulating during the 2022 monkeypox virus outbreak

The effects of amino acid substitutions on the affinity of the SARS-CoV-2 spike RBD to the human receptor hACE2

3 shots in 1: How microparticles could be used to deliver self-boosting vaccines

The first dose response for SARS-CoV-2 solution exposed to UV222

Outlook towards Monkeypox vaccination in healthcare workers of France and Belgium

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News